Xudong Wei

Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma

Lu Han, Jishuai Zhang, Jian Zhou et al. · Leukemia · 2021 · 50 citations · Full text

Hematological Malignancy, Medicine, Immunology +8

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Lu Han, Jian Zhou, Keshu Zhou et al. · Journal for ImmunoTherapy of Cancer · 2020 · 44 citations · Full text

Development of a concise, scalable synthesis of a CCR1 antagonist utilizing a continuous flow Curtius rearrangement

Maurice A. Marsini, Frédéric G. Buono, Jon C. Lorenz et al. · Green Chemistry · 2017 · 42 citations

Combinatorial Chemistry, Robust Synthesis, Ccr1 Antagonist +10

MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1

Jindong Li, Qingchuan Feng, Xudong Wei et al. · Tumor Biology · 2016 · 39 citations

Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study

Lixin Wang, Jianmin Luo, Guofeng Chen et al. · Clinical Epigenetics · 2020 · 38 citations · Full text